The Correlation Between Sevoflurane and qNOX

January 20, 2020 updated by: China International Neuroscience Institution

The Prospective Observational Research of the Analgesic Effect of Sevoflurane and the Correlation Between Sevoflurane and qNOX

This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the correlation between the sevoflurane and NOX index.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the analgesia effect of the sevoflurane.

And test the correlation between the sevoflurane and NOX index.

Study Type

Observational

Enrollment (Actual)

58

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China, 100053
        • Bei Liu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

only elective thoracoscope surgery patients were enrolled

Description

Inclusion Criteria:

  1. Elective thoracoscope surgery patients
  2. Age ranging from 25 to 85 years
  3. American Society of Anesthesiologists (ASA) Physical Status score of 2 to 4
  4. a body mass index (BMI) ranging from 18.5 to 40 kg/m2.

Exclusion Criteria:

  1. Clinical diagnosis of Alzheimer's Disease
  2. implanted pacemaker
  3. Clinical diagnosis of psychiatric diseases
  4. Clinical diagnosis of epilepsy
  5. Clinical diagnosis of autonomic nervous system disorders which might affect the EEG

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The sevoflurane application correlated with the qNOX index
Time Frame: through study completion, an average of 1 year
The sevoflurane application correlated with the qNOX index, meanwhile reflect the analgesia effect of sevoflurane application
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

China International Neuroscience Institution

Investigators

  • Principal Investigator: Xiaohua Wang, MD,PHD, Xuanwu Hospital, Beijing

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 11, 2019

Primary Completion (Actual)

September 1, 2019

Study Completion (Actual)

September 1, 2019

Study Registration Dates

First Submitted

August 4, 2018

First Submitted That Met QC Criteria

September 8, 2018

First Posted (Actual)

September 11, 2018

Study Record Updates

Last Update Posted (Actual)

January 22, 2020

Last Update Submitted That Met QC Criteria

January 20, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CINI-ZYLX-201806-11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nociceptive Pain

Clinical Trials on nociception index qNOX

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe